Morinaga & Co Ltd operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morinaga & Co Ltd with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 39.86 billion Indian Rupees [US$617.10 million]
Imuraya Group Company Limited
(42.00 billion Japanese Yen [US$377.56 million]
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$376.69 million]
Morinaga & Co Ltd reported sales of ¥199.48 billion (US$1.79 billion)
March of 2017.
increase of 9.7%
versus 2016, when the company's sales were ¥181.87 billion.
Sales at Morinaga & Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 36%).